Results 211 to 220 of about 380,997 (339)

Patient‐reported outcome measures in prostate research: a scoping review

open access: yesBJU International, Volume 137, Issue 2, Page 241-250, February 2026.
Objectives To summarise how patient‐reported outcome measures (PROMs) are used in prostate research, specifically in the 10 years after the 2010 CONsolidated Standards Of Reporting Trials (CONSORT) guidelines were introduced. Methods The search was focussed on randomised controlled trials (RCTs) reporting in the top 15 journals in oncology, urology ...
Grace J. Young   +6 more
wiley   +1 more source

Long‐term outcomes of a cascading salvage strategy for high‐risk non‐muscle‐invasive bladder cancer

open access: yesBJU International, Volume 137, Issue 2, Page 339-347, February 2026.
Objective To report long‐term oncological outcomes of patients with high‐risk non‐muscle‐invasive bladder cancer (HR‐NMIBC) undergoing bladder‐sparing therapy (BST) after bacillus Calmette–Guérin (BCG) failure. Patients and Methods We retrospectively reviewed patients with HR‐NMIBC treated from 2000 to 2025 with intravesical therapies after BCG failure,
Ian M. McElree   +5 more
wiley   +1 more source

Precision Care for Hereditary Urologic Cancers: Genetic Testing, Counseling, Surveillance, and Therapeutic Implications. [PDF]

open access: yesCurr Oncol
Somoto T   +11 more
europepmc   +1 more source

[Malignant urologic neoplasms and HLA antigen (1)].

open access: yesNihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1983
I, Kondo   +4 more
openaire   +1 more source

Drug‐releasing intravesical floating technology for sequential gemcitabine and docetaxel in non‐muscle‐invasive bladder cancer

open access: yesBJU International, Volume 137, Issue 2, Page 360-367, February 2026.
Objectives To develop a drug‐releasing intravesical floating technology (DRIFT) device for controlled sequential delivery of gemcitabine and docetaxel (Gem/Doce) to optimise the treatment of non‐muscle‐invasive bladder cancer (NMIBC) while enabling patient mobility and self‐removal, as sequential intravesical Gem/Doce has been increasingly utilised but
Ashley C. Rhodes   +11 more
wiley   +1 more source

Prostate zonal impact of 5α‐reductase inhibitors on multiparametric MRI characteristics and detection of prostate cancer

open access: yesBJU International, Volume 137, Issue 2, Page 332-338, February 2026.
Objectives To assess the impact of 5α‐reductase inhibitors (5‐ARIs) on multiparametric magnetic resonance imaging (mpMRI) features of Prostate Imaging‐Reporting and Data System (PI‐RADS) lesions and their influence on the detection of clinically significant prostate cancer (csPCa), with a focus on differences between prostate zones.
Arighno Das   +12 more
wiley   +1 more source

Readability Optimization of Layperson Summaries in Urological Oncology Clinical Trials: Outcomes from the BRIDGE-AI 8 Study. [PDF]

open access: yesCurr Oncol
Cano I   +12 more
europepmc   +1 more source

Comparison of short‐term complications after open, laparoscopic and robot‐assisted radical prostatectomy

open access: yesBJU International, Volume 137, Issue 2, Page 348-359, February 2026.
Objective The objective of this study is to address the lack of real‐life study comparing the impact of the three surgical approaches for radical prostatectomy (RP), i.e., open (ORP), laparoscopic (LRP) and robot‐assisted (RARP), on the occurrence of postoperative events by measuring the association between surgical approach and risk of death, transfer
Prescillia Nunes   +5 more
wiley   +1 more source

Impact of Diagnosis of Urologic Cancer on Male Sexuality and Patients' Perceptions of Health Professional's Approach. [PDF]

open access: yesInt Braz J Urol
Barros R   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy